LifeMD, Inc. (LFMD)
NASDAQ: LFMD · Real-Time Price · USD
13.75
+0.21 (1.55%)
At close: Jun 27, 2025, 4:00 PM
13.48
-0.27 (-1.96%)
After-hours: Jun 27, 2025, 7:58 PM EDT
LifeMD Revenue
LifeMD had revenue of $65.70M in the quarter ending March 31, 2025, with 48.83% growth. This brings the company's revenue in the last twelve months to $234.01M, up 43.07% year-over-year. In the year 2024, LifeMD had annual revenue of $212.45M with 39.27% growth.
Revenue (ttm)
$234.01M
Revenue Growth
+43.07%
P/S Ratio
2.48
Revenue / Employee
$762,239
Employees
307
Market Cap
624.90M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 212.45M | 59.91M | 39.27% |
Dec 31, 2023 | 152.55M | 33.51M | 28.15% |
Dec 31, 2022 | 119.03M | 26.16M | 28.16% |
Dec 31, 2021 | 92.88M | 55.58M | 149.04% |
Dec 31, 2020 | 37.29M | 24.83M | 199.10% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
LFMD News
- 3 days ago - LifeMD: Inflection Into Profitability Should Drive Stock Upward - Seeking Alpha
- 4 days ago - LifeMD: An Overlooked GLP-1 Beneficiary - Seeking Alpha
- 5 days ago - LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock - GlobeNewsWire
- 19 days ago - LifeMD to Participate in Two Investor Conferences During June - GlobeNewsWire
- 24 days ago - LifeMD: Growth, Growth, And More Growth - Seeking Alpha
- 5 weeks ago - Top 2 Health Care Stocks That May Implode In Q2 - Benzinga
- 5 weeks ago - LifeMD Collaborates with Novo Nordisk to Launch $299 Introductory Bundle for Self-Pay Patients Prescribed Wegovy® - GlobeNewsWire
- 6 weeks ago - LifeMD to Participate in Three Investor Conferences During May - GlobeNewsWire